by X Zheng 2024 Cited by 17In this review, we discuss clinical drugs that have benefited patients with GBM, cancer immunotherapy for GBM, summarize new drug targets of GBM, and review
Glioblastoma Multiforme (GBM) is the most frequent glioma with a poor prognosis. The mainstay treatment for GBM is chemotherapy, but the average survival of GBM remains unsatisfactory due to therapeutic resistance. Poor permeability restricted by the Blood Brain Barrier (BBB) and the presence of Gli
Developed at Johns Hopkins, these wafers dissolve naturally and gradually release chemotherapy drugs into the tumor area over time. Another chemotherapy drug called temozolomide was approved by the FDA in 2024 and is commonly used to treat GBMs and other advanced brain cancers.
by X Zheng 2024 Cited by 17Lomustine is the only chemotherapy drug that can improve the efficacy of BV in patients with recurrent GBM. Lomustine can pass through the BBB
One of the chemotherapy drugs used to treat GBM is temozolomide. But people live, on average, for just months after they are diagnosed and
by N Gonzalez 2024chemosensitivity in glioma cells: chemotherapeutic drugs. A) IC50 chemotherapy in patients with glioblastoma (GBM): a surveillance.
The current standard treatments for GBM include a combination of surgical resection, radiation, and chemotherapy. At present, there are only two drugs approved by the FDA to treat GBM via systematical administration: temozolomide (TMZ) for the treatment of newly diagnosed GBM (ndGBM) and bevacizumab for the treatment of recurrent GBM (rGBM) (2, 3).
by M Sun 2024 Cited by 6Temozolomide is applied as the standard chemotherapy agent in patients with glioblastoma (GBM) after surgery chemotherapy drugs.
The notorious nature of GBM in the context of resistance to chemotherapy has been a major obstacle during the development stages of efficacious therapy for its treatment. Presently, the anti-GBM drug armory mainly relies on temozolomide (TMZ), an oral alkylating agent, as the first-line chemotherapeutic drug in GBM treatment.
Comments